01
Fund I
The fund size is US$150M. The primary investment areas focus on enterprise software, autonomous systems, AI, IoT, robotics & drones, information security, next-gen semiconductors, sensors, and cloud infrastructure.
Funds
Updated：
- TransferGo announces strategic investment from Taiwania Capital to boost growth in Asia Pacific
- APrevent Medical Inc. Secures $6 Million in Series D Funding Led by Taiwania Capital
- Ethernovia Unveils World’s First Single and Quad Port, 10G to 1G Automotive PHY in 7nm
- Artilux Announces Groundbreaking GeSi SPAD Research Published in Nature Journal. Achieving a new milestone in CMOS photonics
- Global Travel Platform Daytrip Closes $10M Series B Round
02
Fund II
With a fund size of US$200M, Fund II invests in companies with disruptive and advanced technologies which address unmet medical needs. The key investment thesis is to bridge Taiwan innovations with the global biotech industry.
03
Fund III
With a fund size of US$59M, Fund III focuses on investments in Medtech startups that develop therapeutic/diagnostic devices or precision health-related medical technology. Taiwania will help Medtech startups to optimize their growth, new product launches, and new market entry.
05
Fund V
The fund size is US$56M. The primary investment areas focus on early startups specialize in automation, enterprise SaaS, 5G and networking, advanced manufacturing, and digital health.
06
Fund VI
The fund size is US$200M. Focusing on topics such as new edge and 5G infrastructure, EV supply chain, Hybrid next generation Semi and data/ML security and lifecycle.
- Rm. 1806, 18F., No. 333, Sec. 1, Keelung Rd., Xinyi Dist., Taipei City 11012 , Taiwan (R.O.C.)
- Taiwania Capital Management USA, Inc 3945 Freedom Circle, Suite 760, Santa Clara, CA 95054